Effect of high-dose intravenous iron injection on hepatic function in a rat model of cirrhosis
Ji-Hye Kwon,RyungA Kang,Sangmin Maria Lee,Tae Soo Hahm,Hyun Sung Cho,Gayoung Jin,Justin Sangwook Ko
DOI: https://doi.org/10.1177/03000605241253733
2024-05-30
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 52, Issue 5, May 2024. ObjectiveTo investigate the hepatic effects of high-dose intravenous (IV) iron, including those on liver function and the degree of fibrosis, in a rat model of cirrhosis.MethodsWe evenly allocated 25 Sprague–Dawley rats into five groups: normal rats (control group), cirrhotic rats receiving IV normal saline (liver cirrhosis [LC] group), and cirrhotic rats receiving 20, 40, or 80 mg/kg IV ferric carboxymaltose (LC-iron20, LC-iron40, and LC-iron80 group, respectively). Biochemical parameters were compared at 0, 7, 14, 21, and 28 days. The degrees of hepatic fibrosis and iron deposition were evaluated. Inflammatory and oxidative stress markers were also compared.ResultsThere were no significant differences in the 28-day serum alanine aminotransferase levels among the LC-iron20, LC-iron40, and LC-iron80 groups (69 ± 7, 1003 ± 127, 1064 ± 309, 919 ± 346, and 820 ± 195 IU/L in the control, LC, LC-iron20, LC-iron40, and LC-iron80 groups, respectively). Hepatic iron accumulation increased in a dose-dependent manner, but the degree of hepatic fibrosis was comparable among the groups. The inflammatory and oxidative stress marker levels did not differ significantly according to the IV iron dose.ConclusionsAdministration of IV iron at various high doses appears safe in our rat model of cirrhosis.
pharmacology & pharmacy,medicine, research & experimental